Q25.72 Congenital pulmonary arteriovenous malformation

Name of the Condition

• Congenital pulmonary arteriovenous malformation

Summary

Congenital pulmonary arteriovenous malformation (PAVM) is a rare birth defect involving abnormal connections between the pulmonary arteries and veins in the lungs. These abnormal vessels bypass the normal capillary network, allowing deoxygenated blood to mix with oxygenated blood, which can lead to reduced oxygen levels in the bloodstream. PAVMs may be single or multiple and can vary in size and complexity.

Causes

The condition arises from developmental abnormalities during fetal lung formation, where direct connections between arteries and veins form without an intervening capillary bed. It is often associated with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder affecting blood vessel formation. In some cases, PAVMs may occur as an isolated defect without a known genetic link.

Risk Factors

• Family history of hereditary hemorrhagic telangiectasia (HHT)
• Genetic mutations associated with HHT (e.g., ENG, ACVRL1, SMAD4 genes)
• Presence of other congenital vascular anomalies

Symptoms

• Shortness of breath or difficulty breathing, especially during exertion
• Cyanosis (bluish discoloration of the skin or lips)
• Fatigue or weakness
• Nosebleeds or other unexplained bleeding
• clubbing of the fingers or toes in chronic cases

Diagnosis

Diagnosis typically involves imaging studies to visualize the abnormal vascular connections. Contrast echocardiography may detect right-to-left shunting, while computed tomography (CT) angiography or magnetic resonance (MR) angiography provides detailed images of the pulmonary vasculature. Pulmonary angiography remains the gold standard for confirming and mapping PAVMs.

Treatment Options

• Embolization: Minimally invasive procedure using coils or plugs to block abnormal vessels
• Surgical resection: Removal of large or complex PAVMs
• Observation: For small, asymptomatic PAVMs with low risk of complications
• Management of associated conditions (e.g., HHT) to reduce bleeding risk

Prognosis and Follow-Up

Prognosis depends on the size, number, and location of PAVMs, as well as the presence of underlying conditions like HHT. Untreated PAVMs can lead to complications such as stroke, brain abscess, or pulmonary hemorrhage. Regular monitoring with imaging is recommended to assess for changes or new lesions, especially in patients with HHT.

Complications

• Stroke or transient ischemic attack due to paradoxical emboli
• Brain abscess or other systemic infections
• Pulmonary hemorrhage or hemoptysis
• Hypoxemia (low blood oxygen levels)
• High-output heart failure in severe cases

Lifestyle & Prevention

• Avoid activities that increase the risk of air bubbles entering the bloodstream (e.g., scuba diving)
• Manage underlying conditions like HHT to reduce bleeding risk
• Quit smoking to improve lung function and overall vascular health
• Maintain regular follow-up with a pulmonologist or cardiologist

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden shortness of breath or chest pain
• Unexplained bleeding (e.g., nosebleeds, coughing up blood)
• Cyanosis or bluish skin discoloration
• Neurological symptoms (e.g., weakness, confusion, or vision changes)

Tips for Medical Coders

When coding for congenital pulmonary arteriovenous malformation (Q25.72), ensure documentation supports the congenital nature of the condition. Include details about associated genetic syndromes (e.g., HHT) or comorbidities if present, as these may impact coding specificity. Verify that imaging or diagnostic results confirm the abnormal arteriovenous connection in the lungs. Avoid coding for acquired PAVMs, as this code is specific to congenital cases.